cardiovascular · Mechanism Report
Does the LDLR rs6511720 GG genotype align with higher LDL cholesterol?
The LDLR rs6511720 T allele is associated with lower LDL cholesterol, while the GG genotype lacks this LDL-lowering variant and aligns with higher LDL-family cholesterol.
This is what AI claimed
LDLR rs6511720 T allele is associated with lower LDL cholesterol, so GG lacks this LDL-lowering variant and can align with higher LDL-family cholesterol
Executive summary
This claim says the rs6511720 T allele in LDLR is linked to reduced LDL cholesterol, whereas GG means the protective variant is absent. The mechanism described is increased LDL receptor expression and LDL clearance with the T allele, so non-carriers have the usual baseline clearance and higher circulating LDL. The graph also frames LDL cholesterol as part of the pathway connected to coronary heart disease risk.
Verified conclusion
The LDLR gene plays a critical role in cellular cholesterol homeostasis by encoding the low-density lipoprotein receptor responsible for clearing LDL particles from circulation. Variations within this gene, specifically the rs6511720 single nucleotide polymorphism, significantly influence individual lipid profiles.
Clinical evidence
- T Allele Protective Effects: Large-scale genome-wide association studies (GWAS) demonstrate that each copy of the minor T allele of rs6511720 is associated with a reduction of approximately 7 to 8 mg/dL in circulating LDL cholesterol (LDL-C), which translates to a lower risk of coronary heart disease.
- GG Genotype and Elevated Lipids: Individuals with the GG genotype lack this protective variant. Consequently, they display higher baseline LDL-C levels, with cohort data showing GG homozygotes (particularly females) have elevated odds of presenting with higher LDL-C tiers (e.g., ≥130 mg/dL) compared to GT or TT carriers.
Mechanistic explanations
- Enhancer Activity: The rs6511720 T allele functions as a functional intronic enhancer. It alters the DNA sequence to strengthen the binding of transcription factors, such as serum response element (SRE) binding proteins, in hepatocytes.
- Receptor Expression and Clearance: This enhanced binding boosts LDLR promoter activity and transcription. The resulting increase in cell-surface LDL receptor expression facilitates more efficient hepatic clearance of circulating LDL particles. Non-carriers (GG genotype) lack this transcription-boosting mechanism, leading to standard baseline clearance and higher circulating levels of LDL-family cholesterol.
Bottom line
- The LDLR rs6511720 T allele is a well-established regulatory variant that lowers LDL-C by increasing receptor expression. Individuals with the GG genotype lack this protective enhancer variant, which naturally aligns them with higher baseline LDL-C levels and a standard, unreduced risk profile for coronary heart disease.
References
- Identification of the Functional Variant(s) that Explain ... — pubmed.ncbi.nlm.nih.gov
- Table 3. Meta-analysis of GWAS–identified LDL-C SNPs. — pmc.ncbi.nlm.nih.gov
- Online Mendelian Inheritance in Man (OMIM) — omim.org
- Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD — dx.plos.org
- Identification of the Functional Variant(s) that Explain the Low ... — journals.plos.org
- Sex-specific effect of the LDL-receptor rs6511720 ... — inase.org
- HEART HEALTH | LDLR (rs6511720) — plexusdx.com
- Pleiotropic cardiometabolic effects of the LDLR rs6511720 T allele: an evaluation of genetic risk across metabolic states. — linkinghub.elsevier.com
- Pleiotropic cardiometabolic effects of the LDLR rs6511720 T allele: an evaluation of genetic risk across metabolic states - PubMed — pubmed.ncbi.nlm.nih.gov
- Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study — journals.plos.org
See a full patient report verified like this
Book a walkthrough